Hostname: page-component-7b7567c8c-tnzcf Total loading time: 0 Render date: 2026-11-14T08:51:45.379Z Has data issue: false hasContentIssue false
  • English
  • Français

Germ-Line Gene Therapy: Keep the Window Open a Crack*

Published online by Cambridge University Press:  17 May 2016

Robert Mullan Cook-Deegan
Robert Mullan Cook-Deegan*
Affiliation:
Institute of Medicine, USA
Get access

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Symposium: Regulating Germ-Line Gene Therapy
Information
Politics and the Life Sciences , Volume 13 , Issue 2 , August 1994, pp. 217 - 220
Copyright
Copyright © Association for Politics and the Life Sciences 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Bonnicksen, A.L. (1994). “National and International Approaches to Human Germ-Line Gene Therapy.” Politics and the Life Sciences 13:39–49.CrossRefGoogle Scholar
Danks, D.M. (1994). “Germ-Line Gene Therapy: No Place in Treatment of Genetic Disease.” Human Gene Therapy 5:151–52.CrossRefGoogle Scholar
Gordon, J.W. and Ruddle, F. (1981). “Integration and Stable Germ Line Transmission of Genes Injected into Mouse Pronuclei.” Science 214:1244–46.Google Scholar
Group C: Human Gene Therapy (1991). “Report of Working Group C.” In Bankowski, Z. and Capron, A.M.(eds.), Genetics, Ethics, and Human Values. Geneva: Council of International Organizations of Medical Sciences.Google Scholar
Neel, J.V. (1993). “Germ-Line Gene Therapy: Another View.” Human Gene Therapy 4:127–28.CrossRefGoogle Scholar
Office of Technology Assessment, U.S. Congress (1984). Human Gene Therapy: A Background Paper. OTA-BP-BA-32. Washington, DC: U.S. Government Printing Office.Google Scholar
Palmiter, R.D., Brinster, R.L., Hammer, R.E., Trumbauer, M.E., Rosenfeld, M.G., Brinberg, N.C., and Evans, R.M. (1982). “Dramatic Growth of Mice That Develop from Eggs Microinjected with Metallothionein-Growth Hormone Fusion Genes.” Nature 300:611–15.CrossRefGoogle Scholar
President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research (1982). Splicing Life. Washington, DC: U.S. Government Printing Office.Google Scholar
Rifkin, J. (1983). Algeny. New York: Viking.Google Scholar
Thompson, L. (1994). Correcting the Code. New York: Simon and Schuster.Google Scholar
de Wachter, M.A.M. (1993). “Ethical Aspects of Human Germ-Line Therapy.” Bioethics 7:166–77.Google Scholar
Wivel, N.A. and Walters, L. (1993). “Germ-Line Modification and Disease Prevention: Some Medical and Ethical Perspectives.” Science 262:533–38.Google Scholar